HemaSphere (Jun 2022)

S243: ANTIBODY AND T-CELL RESPONSE SIX MONTHS AFTER INITIATION OF BNT162B2 VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA OR CHRONIC LYMPHATIC B-CELL LEUKEMIA COMPARED TO HEALTHY CONTROLS

  • L. D. Heftdal,
  • L. Pérez-Alós,
  • S. R. Ham,
  • J. R. Madsen,
  • K. Fogh,
  • C. C. Kronborg,
  • A. P. Vallentin,
  • R. B. Hasselbalch,
  • S. R. Ostrowski,
  • R. Frikke-Schmidt,
  • E. Sørensen,
  • L. Hilsted,
  • H. Bundgaard,
  • K. Iversen,
  • P. Garred,
  • S. D. Nielsen,
  • K. Grønbæk

DOI
https://doi.org/10.1097/01.HS9.0000843864.94970.a3
Journal volume & issue
Vol. 6
pp. 144 – 145

Abstract

Read online

No abstracts available.